Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6535
    +0.0012 (+0.18%)
     
  • OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD

    2,349.60
    +7.10 (+0.30%)
     
  • Bitcoin AUD

    97,802.09
    -1,660.73 (-1.67%)
     
  • CMC Crypto 200

    1,383.71
    -12.82 (-0.95%)
     
  • AUD/EUR

    0.6108
    +0.0035 (+0.57%)
     
  • AUD/NZD

    1.0994
    +0.0037 (+0.33%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,718.30
    +287.79 (+1.65%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,239.66
    +153.86 (+0.40%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Company News for Oct 9, 2020

  • Shares of Coty Inc. COTY jumped 12.3% after the company announced expansion of Kylie Skin in the UK, France, Germany and Australia.

  • Eaton Vance Corp.’s EV shares surged 48.1% after Morgan Stanley announced plans to acquire the company for $7 billion.

  • Shares of AeroVironment, Inc. AVAV rose 6.5% after the company reported that Sunglider solar HAPS successfully completed its stratospheric test flight, surpassing 60,000 feet altitude and demonstrating broadband mobile broadband communication.

  • Jazz Pharmaceuticals plc’s JAZZ shares jumped 8% after the company announced top-line results from its Phase 3 study of Xywav Oral Solution in adult patients with Idiopathic Hypersomnia.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Jazz Pharmaceuticals PLC (JAZZ) : Free Stock Analysis Report
 
Eaton Vance Corporation (EV) : Free Stock Analysis Report
 
AeroVironment, Inc. (AVAV) : Free Stock Analysis Report
 
Coty Inc. (COTY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research